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ABstrAct: 
Humans and animals realize cost/benefits analysis of our responses with the goal of use the lowest 
energy possible to obtain the major benefit. Mesolimbic dopamine (DA) is a critic component in 
the cerebral circuitry regulating decision making based on the effort that the response requires, 
because it regulates behavioral activation. Research with rodents show that DA antagonists displace 
the behavior from the response that supposes more effort, though it has more reinforcement, to other 
behavior with less effort required. Interaction between A2A adenosine receptors and D2 receptors 
play an essential paper in these processes. In the T-Maze paradigm the animal is exposed to an 
option of choose one arm with two food pellets, to which it accedes after climbing a 14 cm barrier, 
or to choose the arm without barrier and with only one food pellet. Control animals choose to do the 
effort of climbing the barrier to obtain the high reinforcement. Haloperidol, D2 antagonist, produces 
change behavior towards the less density arm, been this effect partially reverted with theophylline, 
unspecific adenosine antagonist, and with MSX-3, selective A2A antagonist. These drugs could have 
applications for the treatment of amotivational syndromes. 
introDuction
Definition and components of motivation
Motivation has been defined as the set of processes through which organisms regulate the probability, 
proximity and availability of certain stimuli (Salamone, 1992; Salamone and Correa, 2002). Through 
motivational processes organisms direct their efforts towards a certain goal, whether it is consuming 
food, drinking or engaging in mating behavior (Salamone et al., 1992). Thus, motivation plays an 
integral role in the execution of decision making in everyday life. As different reinforcing stimuli 
involve varying work requirements, organisms make effort related choices based upon analyses of the 
energy cost of the action relative to the magnitude of the organism’s benefit from such actions.  The 
employment of cost/benefit analyses determine the executed behavior of the organism and are crucial 
to motivational processes (Salamone and Correa, 2002). Additionally, obstacles such as environmental 
constrains play an integral role in such cost/benefit analyses. Instrumental behaviors often entail a high 
degree of vigorous work output from the organism to overcome such barriers to obtain the reinforcer 
(Salamone and Correa 2002; Farrar et al., 2007). In behavioral research, two prominent aspects of 
motivational processes include directional or goal directed behaviors, aspect of motivation that refers 
to the fact that motivated behavior is either directed towards or away from a particular stimulus, and 
the activational aspects of motivated behaviors, pertaining to the speed, vigor and persistence in the 
pursuit of a reinforcing stimulus (Salamone and Correa, 2002). 
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The concepts of “drive” and “incentive” offered by Hull et al. (1991) and Spence (1956) emphasized 
that motivational conditions can produce energizing effects on behavior. Researchers who conducted 
early studies of the neural basis of motivation and emotion emphasized the role that arousal and 
“energy mobilization” played in these processes (e.g., Lindsley 1951; Moruzzi and Magoun 1949; 
Rubio-Chevannier et al. 1961).
It has been suggested that interference with DA transmission impairs activational aspects of food 
motivation but leaves intact directional aspects (Salamone 1988, 1997, 1992; Barbano and Cador 2006). 
This idea is not only related to locomotion or schedule-induced activity but is also highly relevant for 
food-reinforced instrumental behaviors. Lots of studies demonstrate that the effects of dopaminergic 
manipulations on indices of behavioral activation in food related tasks are not simply dependent upon 
changes in primary food motivation or appetite. Instead, the preponderance of evidence suggests 
that these experiments serve to dissociate dopaminergic involvement in behavioral activation from 
processes mediating primary food motivation or appetite (Salamone 1988, 1992; Salamone et al. 
1997, 2003; Kelley et al. 2005). Consistent with this, it has been suggested that interference with 
DA transmission impairs activational aspects of food motivation but leaves intact directional aspects 
(Salamone 1988, 1997, 1992; Barbano and Cador 2006).
Neuroanatomy of Motivation: The Basal Ganglia
Basal ganglia (BG) consist of a collection of forebrain nuclei relevant for the control of a variety of 
behavioral functions, among which can be included motor and non motor functions (McDonald & 
White, 1993; Redgrave et al., 1999). 
Traditionally the nuclei included in the BG are striatal areas such as the caudate, putamen, nucleus 
accumbens (Nac), and globus pallidus. Associated areas include the substantia nigra and the subthalamic 
nucleus. Collectively, the caudate and putamen are referred to as the dorsal striatum whereas the Nac 
and olfactory tubercle are often collectively referred to as the ventral striatum (Nolte, 2007). BG as a 
whole serves as one of many circuits involved in motor function and motivated behaviors. 
The Nac is a subregion of the ventral striatum, a collection of neurons located at the junction of the 
head of the caudate and the septum pellucidum (Kelley et al., 1997; Salamone, 1996). The Nac can 
be divided into core and shell subregions based on anatomical and biochemical differences (Jongen-
Relo et al., 1993, 1994; Meredith et al., 1993; Voorn et al., 1994; Zaborszky et al., 1985), of which 
it has been shown that different effects on motor function occur based on the location of the Nac 
subdivisions (Heimer et al., 1987; Ishiwari et. al., 2007). Mogenson and colleagues (1980) suggested 
that Nac serves as a “limbic-motor” interface that translates motivational and cognitive information 
into action. Distinct subregions and cell groups in nucleus accumbens act as “gates” that allow 
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multiple channels of information to be processed, and the neurotransmitter DA, along with GABA, 
glutamate, acetylcholine, adenosine and other substances, regulate the physiological responses of 
accumbens neurons.
Dopamine in the Striatum
In terms of DA transmission throughout the brain, there are four DA pathways (Nolte, 2007). The 
mesolimbic pathway stems from the VTA and provides the source of the dopaminergic innervation 
to the Nac. It is this pathway that is thought to be involved in motivated behaviors. 
DA in the Nac appears to be one of the critical components of the brain circuitry controlling effort-
related behavioral processes and behavioral activation (Salamone et al., 1991, 1997, 2002, 2003, 
2005, 2007; Yurgelun-Todd et al., 2007; Barbano and Cador 2007; Niv et al., 2007; Phillips et al., 
2007; Robbins and Everitt 2007).  
Adenosine in the Striatum
Recently it has been shown that adenosine plays a role in the modulation of DA transmission within 
the brain and drugs that act on adenosine have been investigated for their potential to serve as a novel 
treatment for Parkinson’s disease (Correa et al. 2004; Ishiwari et al. 2007; Betz et al., 2009). Central 
adenosine neurotransmission plays an important role in modulating the functional circuitry of the 
basal ganglia (Ferré et al., 1997; Svenningsson et al., 1999; Hauber et al., 2001). DA and adenosine 
receptors are known to share a considerable overlap in their regional distribution, being the BG a 
rich place in colocalization of both type of receptors (Short et al., 2006).
A1 and A2A receptors are robustly expressed in the BG, with the A2A subtype predominantly 
expressed in the striopallidal neurons of the “indirect” pathway and Nac (Jarvis and Williams 1989; 
Schiffmann et al., 1991; DeMet and Chicz-DeMet, 2002; (Ferré et al., 1997; 2004). 
This high density of A2A receptors within the ventral striatum, particularly in the Nac, also may be 
an important component of current motivational research, as it has been suggested that adenosine 
also plays a role in aspects of motivated behaviors (Salamone et al., 2007; Farrar et al., 2007). While 
central A2A receptors are expressed almost exclusively in the striatum (Ferre et al., 1993; Pinna 
et al., 2005; Svenningsson et al., 1997; Tanganelli et al., 2004), A1 receptors have a relatively high 
expression throughout the brain; highest densities are found in the stratum oriens, hippocampus, 
cerebral cortex, striatum and thalamus (Fastbom et al., 1986, 1987a,b; Svenningsson et al., 1997).
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Cellular interactions of A2A and D
2
 receptor subtypes
The cellular and molecular bases of the interactions of adenosine and dopamine receptors colocalized 
in striatum have been the subject of considerable interest within the last few years, and several 
possible molecular mechanisms for this interaction have been proposed, among these include the 
finding that D2
 
receptors and A2A
 
receptors (Fink et al., 1992; Ferré 1997; Svenningsson et al.,1999; 
Hillion et al., 2002; Fuxe et al., 2003), as well as D1
 
receptors and A1
 
receptors (Gines et al., 2000), 
have been shown to form heteromeric receptor complexes. 
In the neostriatum, D2 receptors and A2A receptors appear to have opposite functional interactions 
(Ferré et al., 1997). Researchers have recently begun to identify additional functions of adenosine 
A
2A
 receptors related to cognition (Takahashi et al., 2008) and motivation (O’Neill and Brown 2006; 
Farrar et al., 2007; Font et al., 2008; Mingote et al., 2008; Worden et al., 2009; Salamone et al., 2009; 
Mott et al., 2009). 
Dopaminergic involvement in aspects of motivation  
The dopamine (DA) hypothesis of ‘reward’ or reinforcement has become one of the most ubiquitous 
and popular hypotheses in the history of neuroscience. According to this hypothesis, DA systems 
mediate the reinforcing effects of several different classes of stimuli (see Salamone and Correa, 
2002). Considerable research with the taste reactivity paradigm has demonstrated that interference 
with DA by systemic administration of DA antagonists or by local depletions of DA in nucleus 
accumbens or neostriatum failed to alter appetitive taste reactivity for sucrose (Berridge et al., 1998; 
Treit and Berridge, 1990). Pleasure or primary appetitive motivation, are aspects of the motivated 
behavior that are preserved after DA transmission interference (Salamone et al., 2007). 
Substantial evidence indicates that DA systems are involved in activational aspects of motivation 
(Salamone 1992; Salamone et al 1994; Cousins et al., 1996; Salamone et al., 1997; Cousins et al., 
1999; Correa et al., 2002; Farrar et al., 2007). It has been shown that DA receptor antagonism or 
Nac DA depletions induce behavioral impairments that make animals sensitive to work-related 
response costs (Salamone 2007), thus regulating effort-related processes (Salamone, 1988, 1991, 
1992; Salamone et al., 1991, 1997, 2003, 2005; Vezina et al., 2002; Zhang et al., 2003; Wakabayashi et 
al., 2004; Barbano and Cador, 2006; Denk et al., 2005). DA, particularly in the Nac, mediates effort 
related choices (Salamone et al., 1992, 2003, 2005; Denk et al., 2005). Thus, modulating modulates 
the outcome of cost/benefit analyses (Salamone et al., 1991, 1992, 1993, 1994, 2003, 2005; Cousins 
et al, 1994, 1996; Nowend et al. 2001; Farrar et al., 2007). 
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Dopamine-Adenosine interactions on motor and motivated behaviors
In addition to studying DA systems, there has been a growing interest in the last few years that has 
focused upon the interaction between DA and the neuromodulator adenosine. 
There is evidence suggesting that DA-adenosine interactions are involved in accumbens-mediated 
behaviors. MSX-3 (A2A selective receptor antagonist) augmented bar pressing in a FR5 program in 
rats pretreated with haloperidol (D2 receptor antagonist) (Farrar et al., 2007; Mott et al., 2009). The 
same doses administered alone did not produce any effect. Furthermore, this effect is mediated by 
the interaction adenosine/D2 and not with D1 (Worden et al., 2009). 
Studies on the motivational significance of the interaction between DA and adenosine transmission 
in the brain have garnered increasing attention in the scientific community (Farrar et al., 2007; 
Worden et al., 2009; Salamone et al., 2009; Mott et al., 2009).
The T-Maze choice procedure was also developed to study in rats effort based decission making in 
motivated behavior (Salamone et al., 1994; Cousins et al., 1996). In this procedure, two arms of the 
maze have different assigned food densities (four pellets vs. two or four vs. zero). Rats are allowed 
the choice to go and consume a lower amount of food (e.g. 2 pellets) in the low density (LD) arm, 
or obtaining a larger amount of food in the high density (HD) arm, which typically is blocked by 
placement of 44 cm vertical barrier. Rats must then choose either to consume a reduced amount of 
food in the LD arm or scale the barrier to consume a higher amount of food in the HD arm. Depletion 
of accumbens DA or treatment with haloperidol dramatically altered choice behavior when the HD 
arm containing four pellets was blocked by a barrier and the LD arm contained two pellets. Rats 
showed a significant decreased selection of the HD arm and a significantly increased selection of the 
LD arm (Cousins et al., 1996; Salamone et al., 1994). Under test conditions in which no barrier was 
present, rats treated with haloperidol or nucleus accumbens DA depletions did not show a behavioral 
allocation from the HD arm to the LD arm in (Salamone et al., 1994). When the HD arm contained 
four pellets blocked by a barrier, but the low density arm contained no pellets, rats with accumbens 
DA depletions chose to climb the barrier and consume the pellets (Cousins et al., 1996). Rats treated 
with 0.1 mg/kg haloperidol and Nac DA depletions showed significantly increased response latencies 
in both the barrier and non barrier conditions (Salamone et al., 1994; Cousins et al., 1996). These 
results indicate that blockade or depletion of DA did not affect the primary reinforcing nature of food, 
but rather that Nac DA depletions affected the relative allocation of effort-related choice behaviors 
regarding high energy work requirements. 
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In a recent paper (Mott et al., 2009), it was found a significant dose-related reversal effect of MSX-
3 on haloperidol induced shift in the T-maze paradigm with rats (0.75, 1.5 and 3 mg/kg MSX-3). 
However, with DPCPX (A1 receptor antagonist) no reversal effect was seen. 
The present experiments were designed to investigate the ability of an adenosine receptor antagonist 
to reverse the behavioral impairment in T-maze choice induced by blockade of dopaminergic 
transmission with the D2 receptor antagonist haloperidol. 
mAteriAls AnD metHoDs:
Subjects
CD1 male mice (20+2 g), 4 weeks old upon arrival to the laboratory were purchased from Harlan-
Interfauna Ibérica S.A. (Barcelona, Spain). A total of 38 animals were used in the present studies. 
Mice were housed in groups of three per cage with standard laboratory rodent chow and tap water 
available ad libitum. They were maintained in the colony for 7 days prior to experimentation at 22 
+ 2 ºC with lights on from 0800 to 2000 hours. Mice started to be tested after 11 weeks after arrival 
to the laboratory. Mice weighted 27-33 g at the beginning of the study, after that, mice were food-
deprived to 85% free-feeding body weight throughout the study with water available ad libitum in 
the home cages. All experimental procedures complied with European Community Council directive 
(86/609/ECC). 
Pharmacological agents and selection of doses
Haloperidol (Sigma Química C.O), a D2 dopamine receptor selective antagonist, was dissolved in 
a 0.3% tartaric acid solution (pH=4.0). The doses used (0.0 / 0.025 / 0.05 / 0.1 mg/kg) were adapted 
from rat doses used in previous studies (Mott et al., 2009). Tartaric acid solution was the vehicle 
control for the haloperidol dose 0.0 mg/kg. Haloperidol was administered 50 minutes before the 
test.
Theophylline (TOCRIS Bioscience), a nonspecific adenosine receptor antagonist, was dissolved in 
0.9% w/v saline (pH= 7.4). The doses used (0.0 / 5 / 10 / 15 mg/kg) were adapted from mice and rat 
doses used in previous studies (Malec and Poleszak, 2006; Bishnoi et al., 2007). Saline solution was 
used as a vehicle control for theophylline dose 0 mg/kg. Theophylline was administered 20 minutes 
before the test.
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MSX-3 ((E)-phosphoric acid mono – [3-[8-[2-(3- methoxphenyl)vinyl] – 7- methyl-2, 6, - dioxo-1-
prop-2-ynyl-1, 2,6,7 – tetrahydropurin- 3-yl] propyl] ester disodium sald) an A2A adenosine receptor 
selective antagonist synthesized at the laboratory of Dr.Christa Müller at the Pharmazeutisches 
Institut, Universität Bonn, in Bonn, Germany. MSX-3 was dissolved in 0.9% w/v saline (pH= 7.4). 
The doses used (0.0 / 1 / 2 / 3 mg/kg) were adapted from rat doses used in previous studies (Mott 
et al., 2009). Saline solution was used as a vehicle control for MSX-3 dose 0 mg/kg. MSX-3 was 
administered 30 minutes before the test. 
All drugs were administered intraperitoneally (IP). 
Apparatus and testing procedures
Each trial started when the gate in the central arm was opened. It finished when the animal started 
to consume the food located in the selected arm. Immediately after the animal finished consuming 
the food, it returned by itself to the starting arm where was briefly enclosed with the purpose of 
revealing the food. In each trial the mouse had the option of going to any of the two opposed arms 
to consume the pellets. When the mouse had chosen one arm the other arm was blocked. During 
the initial training trials the researcher had to return the animal to the starting arm. This procedure 
was repeated during 30 trials, and that was considered a session. Sessions started two hours after the 
colony lights where on. Animals had one training session per day, 5 days a week. 
Mice were trained in several different phases. During the first training phase no barrier was present. 
The first 2 days of the initial training, mice had free access to both arms of the T-maze upon exiting 
the start arm and allowed to consume all pellets in both HD and LD arms of the maze before being 
returned to the start arm. Upon completion of this initial training, mice were then trained to select 
between the HD or the LD arm, with no barrier in place. The criterion before a new learning phase 
started was set so that animals had to choose 90% of the times the HD arm at least for 2 days. In 
the second phase a small barrier (5.5 cm high) was introduced in the HD arm. In the third phase a 
medium barrier (12 cm high) replaced the short one. Finally, in the fourth training phase and for the 
rest of the experiment, the high barrier (14 cm high) was introduced. During the test phase there was 
one drug day and 4 baseline days before the next drug day. 
To validate the paradigm, other experiment was done where trained animals with the same procedure 
were trained in fifth phase with two 14 cm barriers, one in the HD arm and other in the LD arm. Test 
days the execution was evaluated of the described form previously. Animals receive 0 or 0.1 mg/kg 
haloperidol. Again, it was a within-groups design in a random order. 
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results:
During the following experiments, every day each animal had one training session starting two 
hours after the lights where on. Every training session consisted of 30 trials (See Fig. 1 for a model 
of learning progression, of one of the experiments done). The duration of the phases was: 
Phase 1. No barrier: 3 weeks.
Phase 2. Barrier 5.5 cm high in HD arm: 1 weeks. 
Phase 3. Barrier 12 cm high in HD arm: 1 weeks. 
Phase 4. Barrier 14 cm high in HD arm: 2 weeks before drug test starts. 
Week
1 2 3 4 5 6 7
H
D
 arm
 selectio
n
0
10
20
30
Phase 1 Phase 2 Phase 3 Phase 4
 
Fig.1 Mean + SEM number of HD arm selection by week during all the training phases. 
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Experiment 1: Effect of different doses of haloperidol on effort-related choice behavior
The data for selection of the HD arm (number of barrier crossings) are shown in Fig.1.1 Repeated 
measures ANOVA indicated a significant effect of haloperidol [F(3 ,18 ) = 3,175 , p < 0,05 ]. Planned 
comparisons showed that haloperidol decreased the number of HD arm selections in a significant 
manner, 0.05 (p<0.05) and 0.1 mg/kg (p<0.01). 
Haloperidol Dose (mg/kg)
0 0.025 0.05 0.1
H
D
 arm
 selectio
n
0
5
10
15
20
25
30
Fig. 1.1 Effect of IP administration of haloperidol on HD arm choice in the T-maze. Mean (±SEM) number of HD arm choices after 
treatment with haloperidol (0.0, 0.025, 0.05 and 0.1 mg/kg) administered 50 minutes before testing.  *p<0.05 **p<0.01 significantly 
different from vehicle.
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The data for latency to reach the food are shown in Fig.1.2. Repeated measures ANOVA showed 
a significant effect of haloperidol [F(3 ,18 ) = 3,175 , p < 0,05 ]. Planned comparisons revealed 
significant differences between the lowest dose of haloperidol 0.025 mg/kg and the highest dose 0.1 
mg/kg (p<0.05). 
Haloperidol Dose (mg/kg)
0 0.025 0.05 0.1
C
h
o
ice L
aten
cy (sec)
0
1
2
3
4
Fig. 1.2. Effect of IP administration of haloperidol on T-maze run latency in mice. Mean (±SEM) run latency (average in seconds 
across 30 trials) after treatment with haloperidol (0.0, 0.025, 0.05 and 0.1 mg/kg) administered 50 minutes before testing.
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Experiment 2: Effect of haloperidol on choice behavior in a two barrier T-maze.
The data for selection of the HD arm are shown in Fig.2.1. Repeated measures ANOVA yield a non 
significant effect of haloperidol (0.0, 0.1 mg/kg). 
Haloperidol Dose (mg/kg) 
0 0.1
H
D
 arm
 selectio
n
0
5
10
15
20
25
30
 Fig. 2.1 Effect of IP administration of haloperidol on HD arm selection when the T-maze had two arms with barrier. Mean (±SEM) 
number of HD arm choices after the treatment with haloperidol (0.0 and 0.1 mg/kg) administered 50 minutes before testing.  
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The data for latency to reach the food are shown in Fig.2.2. Repeated measures ANOVA indicated a 
non significant effect of haloperidol doses (0, 0.1 mg/kg). 
Haloperidol Dose (mg/kg)
0 0.1
C
h
o
ice laten
cy (sec)
0
1
2
3
4
5
6
7
Fig. 2.2. Effect of IP administration of  haloperidol on run latency in a T-maze with two barriers, in mice. Mean (±SEM) run latency 
(average in seconds 30 trials) after treatment with haloperidol (0.0 and 0.1 mg/kg) administered 50 minutes before testing.
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Experiment 3: Theophylline modulation of haloperidol effects on effort-related choice in the 
T-maze.
The data for selection of the HD arm after co-administration haloperidol and theophylline are shown 
in Fig.3.1. Repeated measures ANOVA showed a significant effect of drug treatment [F( 4, 44) = 
19.054 , p < 0.01 ]. Planned comparisons revealed significant differences between control condition 
(veh/veh) and all other treatment conditions (p<0.01). The HP/Veh treated group was different from 
HP/10T and HP/15T (p<0.05). 
Drug Treatment 
Veh/Veh HP/Veh HP/5T HP/10T HP/15T
H
D
 arm
 selectio
n
0
5
10
15
20
25
30
Fig 3.1. Effects of the nonspecific adenosine antagonist, theophylline, on T-maze arm choice in mice co-administered haloperidol. 
Mean (±SEM) number of HD arm choices after IP treatment with vehicle (Veh) or haloperidol (HP, 0.1mg/kg, 50 minutes before 
test) plus various doses of theophylline (T; 5.0, 10.0 and 15.0 mg/kg, 20 minutes before test) are shown. **p<0.01 significantly 
different from Veh/Veh; #p<0.05 significantly different from HP/Veh.
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The data for general latency after co-administration haloperidol and theophylline are shown in 
Fig.3.2. Repeated measures ANOVA yield a non significant effect of theophylline treatment. 
Drug Treatment 
Veh/Veh HP/Veh HP/5T HP/10T HP/15T
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Fig. 3.2. Effects of the nonspecific adenosine antagonist, theophylline, on T-maze run latency in mice. Mean (±SEM) run latency 
(average in seconds across 30 trials) after IP treatment with vehicle (Veh) or haloperidol (HP, 0.1mg/kg, 50 minutes before test) plus 
various doses of theophylline (T; 5.0, 10.0 and 15.0 mg/kg, 20 minutes before test) are shown.
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Experiment 4: MSX-3 modulation of haloperidol effects on effort-related choice in the T-maze.
The data for selection of the HD arm after co-administration haloperidol and MSX-3 are shown in 
Fig.4.1. Repeated measures ANOVA indicated a significant effect of drug treatment [ F( 4, 32 ) = 
19,796  , p < 0,01]. Planned comparisons revealed that HP/Veh was significantly different from the 
rest of conditions (p<0.01). There were no differences between Veh/Veh and HP/2M and HP/3M.  
There were not differences between Veh/Veh and the highest two doses of MSX-3.
Drug Treatment
Veh/Veh HP/Veh HP/1M HP/2M HP/3M
H
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 selectio
n
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Fig. 4.1. Effects of the adenosine A2A specific antagonist, MSX-3, on T-maze arm choice in mice co-administered haloperidol. 
Mean (±SEM) number of HD arm choices after IP treatment with vehicle (Veh) or haloperidol (HP, 0.1mg/kg, 50 minutes before 
test) plus various doses of MSX-3 (M; 1.0, 2.0 and 3.0 mg/kg, 20 minutes before test) are shown. **p<0.01 significantly different 
from Veh/Veh; #p<0.05 and ##p<0.01 significantly different from HP/Veh.
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The data for latency to reach the food after co-administration haloperidol and MSX-3 are shown in 
Fig.4.2. Repeated measures ANOVA indicated a non significant effect of MSX-3 treatment. 
Drug Treatment 
Veh/Veh HP/Veh HP/1M HP/2M HP/3M
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Fig. 4.2. Effects of the adenosine A2A specific antagonist, MSX-3, on T-maze run latency in mice. Mean (±SEM) run latency 
(average in seconds across 30 trials) after IP treatment with vehicle (Veh) or haloperidol (HP, 0.1mg/kg, 50 minutes before test) plus 
various doses of MSX-3 (M; 1.0, 2.0 and 3.0 mg/kg, 20 minutes before test) are shown.
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conclusions: 
In the present studies, a T-maze paradigm was used to characterize the effects of the DA D2 
receptor antagonist haloperidol, and to examine the interaction between haloperidol and adenosine 
antagonists. The results with the T-maze barrier task are in accordance with results found with the 
operant procedures in rats (Salamone et al., 1991, 1992, 1996, 2002, 2008, 2009; Cousins et al., 1993; 
1994; Cousins and Salamone 1994; Koch et al. 2000; Sink et al. 2008; Farrar et al.2007, Worden et 
al. 2008). Control animals strongly prefer to climb the barrier to obtain the high density of food. 
D2 antagonism altered the HD arm selection redirecting the behavior towards the less demanding 
response option. 
Theophylline, a nonselective adenosine antagonist, could partially reverse the effects of haloperidol 
(0.1 mg/kg) on the T-maze barrier choice paradigm. Theophylline produced a moderate improvement 
in the selection of the HD arm in haloperidol treated animals at the two highest doses (10 and 
15 mg/kg). Mice redirected their behavior to the HD arm, although not reaching veh/veh levels. 
Latency to reach the food was unaffected after haloperidol plus theophylline treatment. The effects 
of theophylline on the T-maze choice impairment induced by haloperidol are similar to the effects 
of another nonselective adenosine antagonist in the concurrent chow/FR5 schedule operant task 
(Salamone et al., 2009). Caffeine was able to reverse haloperidol effects, but its effect size was 
smaller than the effect of an A2A antagonist (KW6002) but bigger than that produced by an A1 
antagonist (DPCPX; Salamone et al., 2009). 
Co-administration of adenosine A2A antagonist MSX-3 with haloperidol restored the behavior 
towards the highest demanding response option; mice selected to climb the barrier on nearly all of 
the trials. These results were obtained with the two highest doses of MSX-3 used (2.0 and 3.0 mg/
kg), which reached HD choice levels comparable to the veh/veh control group. Only the lowest dose 
MSX-3 used failed to reverse the haloperidol effects. On latency to reach the food these treatments 
did not produce any significant effect. Previous studies with rats on a T-maze and in the operant box 
using MSX-3 and DA D2 antagonists showed the same pattern of results (Mott et al., 2009; Farrar et 
al., 2007, Worden et al., 2008). All these data together demonstrate that A2A antagonism can reverse 
D2 antagonism on a task where an effort-related process is evaluated. 
In summary, present and previous results are seen as consistent with the suggestion that DA 
antagonism alters choice behavior on tasks in which different response options involve different 
effort requirements. Thus, DA antagonists and accumbens DA depletions can be altering behavioral 
activation, instrumental response output, response allocation, or effort-related processes (Salamone 
et al., 2008). 
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As an increasing body of literature emerges detailing the motivational functions of DA, and the 
possible interactions between DA and adenosine, several clinical applications should also be 
recognized. The role of DA is well established in such clinical disorders such as schizophrenia 
and Parkinson’s disease. However DA also is implicated in aspects of depression, including such 
fundamental symptoms as feelings of listlessness, decreased energy levels and fatigue (Stahl, 2002), 
and it had been suggested that the biological basis of fatigue, energy and motivational impairments 
found in depression are unknown (Stahl, 2002). As D2 antagonism induces motor impairments as 
well as motivational impairments in effort related choice procedures, it has been suggested that 
psychomotor slowing in depression may be functionally similar to the impairment in activational 
aspects of motivation that results from a suppression of DA activity in the brain (Salamone et al., 
2007).
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